Tag: Quantum Blue Infliximab

Integration of Controls into BUHMANN Quantum Blue® Assays

Quantum Blue® Lateral Flow Assays: Simple, Fast, Accurate Quantitative Results Now Even More Convenient with 2 Lot Specific Ready-to-use Controls! Available NOW with Integrated Controls: Quantum Blue® Infliximab Assay The BÜHLMANN Quantum Blue® Infliximab is the ONLY quantitative rapid test in the market for infliximab that can provide fast, reliable information for infliximab. The test is designed for the selective

BUHLMANN LabSense News: Winter 2017 Edition

BUHLMANN Diagnostics Corp is proud to release the second edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Here you will also be able to access valuable resources, applications, and other newsworthy items specific to fields of in vitro diagnostics and scientific research. In this edition we

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Tag: Quantum Blue Infliximab

Integration of Controls into BUHMANN Quantum Blue® Assays

BUHLMANN LabSense News: Winter 2017 Edition

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US